Explainer: Could U.S. regulators authorize a COVID-19 vaccine before the election?


  • World
  • Wednesday, 26 Aug 2020

FILE PHOTO: A small bottle labeled with a "Vaccine" sticker is held near a medical syringe in front of displayed "Coronavirus COVID-19" words in this illustration taken April 10, 2020. REUTERS/Dado Ruvic/Illustration

NEW YORK/CHICAGO (Reuters) - U.S. President Donald Trump has said a vaccine for the novel coronavirus could be available before the Nov. 3 presidential election, sooner than most experts anticipate.

A COVID-19 vaccine as early as October could become a reality if drugmakers deliver on optimistic timelines for completing large, late-stage clinical trials and regulators allow for its use prior to a full review and approval.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Chinese company breaks ground on Serbia's National Stadium
2nd LD Writethru: U.S. Fed keeps interest rates unchanged at 5.25-5.5 pct as inflation ticks up
Missile strikes Ukrainian port of Odesa, 13 injured, regional governor says
U.S. stocks close mixed
Crude futures settle lower
Feature: Surging restaurant prices in T�rkiye make eating out a luxury
U.S. dollar ticks down
1st LD: U.S. Fed keeps interest rates unchanged at 5.25-5.5 pct as inflation ticks up
Urgent: U.S. Fed keeps interest rates unchanged at 5.25-5.5 pct as inflation ticks up
FLASH: U.S. FED KEEPS RATES UNCHANGED AT 5.25-5.5 PCT

Others Also Read